ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

PTN Palatin Technologies Inc New

2.04
0.04 (2.00%)
May 20 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 93,584
Bid Price
Ask Price
News -
Day High 2.11

Low
1.43

52 Week Range

High
5.65

Day Low 2.00
Share Name Share Symbol Market Stock Type
Palatin Technologies Inc New PTN AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
0.04 2.00% 2.04 17:09:30
Open Price Low Price High Price Close Price Previous Close
2.00 2.00 2.11 2.04 2.00
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
720 93,584 US$ 2.04 US$ 190,507 - 1.43 - 5.65
Last Trade Type Quantity Price Currency
17:30:00 630 US$ 2.04 USD

Palatin Technologies Inc New Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
32.92M 16.14M - 5.88M -27.54M -1.71 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Palatin Technologies News

Date Time Source News Article
5/15/202407:40Edgar (US Regulatory)Form 8-K - Current report
5/15/202407:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/15/202406:30PR Newswire (US)Palatin Reports Third Quarter Fiscal Year 2024 Financial..
5/09/202406:30PR Newswire (US)Palatin to Report Third Quarter Fiscal Year 2024 Results;..
5/02/202406:30PR Newswire (US)Palatin Announces FDA Clearance of IND Application for the..
4/30/202406:30PR Newswire (US)Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple..
4/08/202406:30PR Newswire (US)Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease..
3/07/202416:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202411:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/28/202406:30PR Newswire (US)Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3..
2/15/202408:00Edgar (US Regulatory)Form 8-K - Current report
2/15/202406:30PR Newswire (US)Palatin Reports Second Quarter Fiscal Year 2024 Financial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PTN Message Board. Create One! See More Posts on PTN Message Board See More Message Board Posts

Historical PTN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.302.481.902.21214,935-0.26-11.30%
1 Month1.842.481.662.08224,9750.2010.87%
3 Months3.113.99291.462.11585,013-1.07-34.41%
6 Months1.975.651.462.70488,4940.073.55%
1 Year2.505.651.432.61290,964-0.46-18.40%
3 Years0.588.600.18110.7876361,235,0231.46251.72%
5 Years1.568.600.18110.79634091,781,3340.4830.77%

Palatin Technologies Description

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.

Your Recent History

Delayed Upgrade Clock